Myo-Inositol Treatment and Gaba-a Receptor Subunit Changes After Kainate- Induced Status Epilepticus

Topics: Hippocampus, Epilepsy, GABAA receptor Pages: 21 (6110 words) Published: February 27, 2013
Cellular and Molecular Neurobiology
ISSN 0272-4340
Volume 33
Number 1
Cell Mol Neurobiol (2013) 33:119-127
DOI 10.1007/s10571-012-9877-4
Myo-Inositol Treatment and GABA-A
Receptor Subunit Changes After Kainate-
Induced Status Epilepticus
Revaz Solomonia, Nana Gogichaishvili,
Maia Nozadze, Eka Lepsveridze, David
Dzneladze & Tamar Kiguradze
Your article is protected by copyright and
all rights are held exclusively by Springer
Science+Business Media, LLC. This e-offprint
is for personal use only and shall not be selfarchived
in electronic repositories. If you
wish to self-archive your work, please use the
accepted author’s version for posting to your
own website or your institution’s repository.
You may further deposit the accepted author’s
version on a funder’s repository at a funder’s
request, provided it is not made publicly
available until 12 months after publication.
Myo-Inositol Treatment and GABA-A Receptor Subunit Changes
After Kainate-Induced Status Epilepticus
Revaz Solomonia • Nana Gogichaishvili •
Maia Nozadze • Eka Lepsveridze • David Dzneladze •
Tamar Kiguradze
Received: 16 July 2012 / Accepted: 17 August 2012 / Published online: 18 September 2012  Springer Science+Business Media, LLC 2012
Abstract Identification of compounds preventing the
biochemical changes that underlie the epileptogenesis
process is of great importance. We have previously shown
that myo-Inositol (MI) daily treatment prevents certain
biochemical changes that are triggered by kainic acid
(KA)-induced status epilepticus (SE). The aim of the current work was to study the further influence of MI treatment
on the biochemical changes of epileptogenesis and
focus on changes in the hippocampus and neocortex of rats
for the following GABA-A receptor subunits: a1, a4, c2,
and d. After SE, one group of rats was treated with saline,
while the second group was treated with MI. Control
groups that were not treated by the convulsant received
either saline or MI administration. 28–30 h after the
experiment, a decrease in the amount of the a1 subunit was
revealed in the hippocampus and MI had no significant
influence on it. On the 28th day of the experiment, the
amount of a1 was increased in both the KA- and
KA ? MI-treated groups. The a4 and c2 subunits were
strongly reduced in the hippocampus of KA-treated animals,
but MI significantly halted this reduction. The effects
of MI on a4 and c2 subunit changes were significantly
different between hippocampus and neocortex. On the
twenty-eighth day after SE, a decrease in the amount of a1
was found in the neocortex, but MI treatment had no effect
on it. The obtained results indicate that MI treatment
interferes with some of the biochemical processes of
Keywords Epilepsy  Kainic acid  Epileptogenesis 
Myo-Inositol  c-Aminobutyric acid receptor subunits
Epilepsy is a heterogeneous group of disorders. It is the
most common neurologic disorder after stroke, with a
2–3 % life time risk that a patient may receive a diagnosis of epilepsy (Browne and Holmes 2001). The available
therapy against epilepsy is only symptomatic and often
ineffective (Loescher et al. 2008). The most important
challenge is to prevent the process of epileptogenesis
(Loescher et al. 2008), not merely to treat its symptoms. At present, there is no anti-epileptic drug (AED) that performs this function (Loescher et al. 2008). Thus, the search for
truly anti-epileptogenic drugs is of outstanding importance
for modern biomedical sciences.
A series of our previous experiments have revealed that a
water extract of the medicinal plant Aquilegia vulgaris contains compounds that alter the binding of ligands to the benzodiazepine and c-aminobutyric acid (GABA) binding sites of
the GABA-A receptors (GABA-AR) (Solomonia et al. 2004).
We have identified two main active compounds from this
extract: (1) myo-Inositol (MI) and (2)...

References: Alldred MJ, Mulder-Rosi J, Lingenfelter SE, Chen G, Luscher B
(2005) Distinct gamma2 subunit domains mediateclustering and
Bencsits E, Ebert V, Tretter V, Sieghart W (1999) A significant part
of native gamma-aminobutyric acid A receptors containing
Brooks-Kayal AR, Raol YH, Russek SL (2009) Alteration of
epileptogenesis genes
Browne TR, Holmes GL (2001) Epilepsy. N Engl J Med
Choi DW (1987) Ionic dependence of glutamate neurotoxicity.
J Neurosci 7:369–379
Clement AB, Hawkins A, Lichtman AH, Cravatt BF (2003) Increased
De Blas AL (1996) Brain GABAA receptors studied with subunit
specific antibodies. Mol Neurobiol 12:55–71
Dietzel I, Heinenmann U, Hofinier G, Lux HD (1982) Stimulusinduced
Res 46:73–84
Dittmer A, Dittmer J (2006) Beta-actin is not a reliable loading
control in western blot analysis. Electrophoresis 27:2844–2845
Dudek FE, Obenaus A, Tasker JG (1990) Osmolality induced changes
Essrich C, Lorez M, Benson JA, Fritschy JM, Luscher B (1998)
Postsynaptic clustering of major GABAA receptor subtypes
Fisher KS, Novak JE, Agranoff BW (2002) Inositol and higher
inositol phosphates in neuronal tissues: homeostasis, metabolism
Moshe SL, Zukin RS (1994) Kainate-induced status epilepticus
alters glutamate and GABA-A receptor gene expression in adult
Gonzalez MI, Brooks-Kayal A (2011) Altered GABA-A receptor
expression during epileptogenesis
Jia F, Pignataro S, Schofield CM, Yue M, Harrison NL, Goldstein PA
(2005) An extrasynaptic GABAA receptor mediates tonic
Joshi S, Kapur J (2009) Slow intracellular accumulation of
GABA(A) receptor delta subunit is modulated by brain-derived
B, Miller ER, Kelly KM, Mtchedlishvili Z (2011) Alterations of
GABA(A) and glutamate receptor subunits and heat shock
Loescher W, Gernert M, Heinemann U (2008) Cell and gene therapies
in epilepsy–promising avenues or blind alleys? Trends Neurosci
Macdonald RL, Kang JQ, Gallagher MJ (2010) Mutations in GABAA
Majores M, Schoch S, Lie A, Becker AJ (2007) Molecular
neuropathology of temporal lobe epilepsy: complementary
Mangan PS, Sun C, Carpenter M, Goodkin HP, Sieghart HP, Kapur J
(2005) Cultured hippocampal pyramidal neurons express two
kinds of GABAA receptors. Mol Pharmacol 67:775–788
McNamara JO, Huang YZ, Leonard AS (2006) Molecular signaling
Nozadze M, Mikautadze M, Lepsveridze E, Mikeladze E, Kuchiashvili
N, Kiguradze T, Kikvidze M, Solomonia R (2011)
Nusser Z, Mody I (2002) Selective modulation of tonic and phasic
Olsen RW, Sieghart W (2009) GABAA receptors: subtypes provide
diversity of function and pharmacology
Walker MC (2011) Progressive loss of phasic, but not tonic
GABA-A receptor-mediated inhibition in dentate granule cells in
Racine RJ (1972) Modification of seizure activity by electrical
stimulation II
Rothman SM (1985) The neurotoxicity of excitatory amino acid is
produced by passive chloride influx. J Neurosci 5:1483–1489
Rowley NM, Smith MD, Lamb JG, Schousboe A, White S (2011)
Schwartzkoin PA, Baraban SC, Hochmann DW (1998) Osmolarity,
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • Is Climate Change Human Induced Essay
  • Women’s Social Status Change Essay
  • The Role of the Amygdala Gaba Receptors and Benzodiazepines in Anxiety Essay
  • After Hope And Change Essay
  • Change After Tragedy Essay
  • Essay on Changes in Psychiatric Treatment
  • Predator-Induced Morphological Changes in an Amphibian: Essay
  • The Changes in Mental Illness Treatment Essay

Become a StudyMode Member

Sign Up - It's Free